Maputo – The Mozambican private business vaccination initiative Univax has so far successfully vaccinated more than 70,000 people across the country against the Covid-19 respiratory disease, according to a press release from Univax on Friday.
319 companies support Univax and on June 30 imported 500,000 doses of the vaccine VeroCell, manufactured by the Chinese pharmaceutical company Sinopharm. As part of an agreement with the Ministry of Health, Univax donated 139,590 doses to the government to immunize the vulnerable population as part of the national vaccination campaign.
The rest is used to vaccinate the workers of the companies concerned and their families. The statement said vaccination is being undertaken directly by companies, through provincial health directorates or through private medical providers.
This vaccination campaign began on July 5 and Univax reports that to date, 72,491 people have received their first dose of the vaccine and 13,401 have already received the second dose.
“This means that in barely a month, the initiative reached, with the first dose, 40% of the target population,” the statement said. He described the initiative as “a collective effort to mass immunize as many workers and their dependents as possible”.
The companies’ goal, the statement added, was “to mitigate the impact of the Covid-19 pandemic on the workforce.” By ensuring the stability of the workforce, it would also reduce the pressure on the state budget and speed up the comprehensive national immunization campaign.